GI
MRNA icon

GS Investments’s Moderna MRNA Stock Holding History

GS Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13
Closed -$869 – 134
2024
Q3 		$869 Hold
13
– – ﹤0.01% 123
2024
Q2 		$1.54K Hold
13
– – ﹤0.01% 117
2024
Q1 		$1.39K Hold
13
– – ﹤0.01% 125
2023
Q4 		$1.29K Sell
13
-35
-73% -$2.94K ﹤0.01% 126
2023
Q3 		$4.96K Hold
48
– – ﹤0.01% 115
2023
Q2 		$5.83K Hold
48
– – ﹤0.01% 114
2023
Q1 		$7.37K Hold
48
– – ﹤0.01% 116
2022
Q4 		$8.62K Hold
48
– – 0.01% 115
2022
Q3 		$6K Hold
48
– – ﹤0.01% 119
2022
Q2 		$8K Hold
48
– – ﹤0.01% 120
2022
Q1 		$7K Hold
48
– – ﹤0.01% 126
2021
Q4 		$12K Buy
+48
New +$14K 0.01% 111

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

GS Investments's MRNA Position: Q4 2024 in Review

GS Investments sold out of Moderna (MRNA) in Q4 2024, closing a stake of 13 shares — an estimated $869 sold.

GS Investments first reported a position in MRNA in Q4 2021 and held it in 12 quarters. The position peaked at $12K in Q4 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • GS Investments reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • GS Investments sold 13 Moderna shares in Q4 2024, an estimated $869.
  • GS Investments first reported a position in Moderna in Q4 2021 and held it in 12 quarters.
  • GS Investments's Moderna position peaked at $12K in Q4 2021.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on GS Investments's 13F filing for Q4 2024, filed 11 Feb 2025.